Cite Filings / VRCA / 0000902664-25-005145

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

Verrica Pharmaceuticals Inc. Filed 2025-11-24 Acc 0000902664-25-005145

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-11-25 4 Chief Operating Officer bought 10,000 shares at $4.24 ($42,425)
2025-11-25 4 CEO and President bought 94,311 shares at $4.24 ($400,114)
2025-11-25 4 CMO bought 2,357 shares at $4.24 ($10,000)
2025-11-25 4 Interim CFO bought 3,536 shares at $4.24 ($15,001)
2025-11-25 4 Director bought 4,126,142 shares at $4.24 ($17,505,157)
2025-11-24 8-K Material agreement · Unregistered share sale · Other events
2025-11-24 SCHEDULE 13D Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…